Cefaclor (Ceclor® - Eli Lilly and Company)

Fogelsong MA Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic. Antimicrob Agents Chemother 1978; 13: 49–52.

Package insert for Ceclor.rG Eli Lilly and Company. March 15, 1979.

Weinstein L. Antimicrobial agents, penicillins, and cephalosporins. In: Goodman LS Gilman A eds. The pharmacological basis of therapeutics. 5th ed. New York: Macmillan Publishing Company, 1975: 1160.

American Medical Association Department of Drugs. AMA drug evaluations. 3rd ed. Littleton, MA: Publishing Sciences Group, 1977: 712–3.

Hodges GR Pharmacological evaluation of cefaclor in volunteers. Antimicrob Agents Chemother 1978; 14: 454–6.

Meyers BR Pharmacologic studies with cefaclor, a new oral cephalosporin. J Clin Pharmacol 1978; 18: 174–9.

Glynne A A human pharmacology study of cefaclor. J Antimicrob Chemother 1978; 4: 343–8.

Santoro J Pharmacology of cefaclor in normal volunteers and patients with renal failure. Antimicrob Agents Chemother 1978; 13: 951–4.

McCracken GH Jr Ginsburg CM. Cefaclor: pharmacokinetics of cefaclor in infants. In: Siegenthaler W Luthy R eds. Current chemotherapy, II. Washington DC: American Society for Microbiology, 1978: 882–4.

Peterson LR Standardization of a preparative ultracentrifuge method for quantitative determination of protein binding of seven antibiotics. J Infect Dis 1977; 136: 778–83.

Bloch R Pharmacokinetics of cefaclor in normal subjects and patients with chronic renal failure. Antimicrob Agents Chemother 1977; 12: 730–2.

Spyker DA Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function. Antimicrob Agents Chemother 1978; 14: 172–7.

Berman SJ Pharmacokinetics of cefaclor in patients with end-stage renal disease and during hemodialysis. Antimicrob Agents Chemother 1978; 14: 281–3.

Korzeniowski OM Comparative pharmacology of cefaclor and cephalexin. Antimicrob Agents Chemother 1977; 12: 157–62.

Meyers BR Hirschman SZ. Antimicrobial activity in vitro of cefaclor, a new oral cephalosporin. J Clin Pharmacol 1978; 18: 85–90.

Bach VT In vitro activity of cefaclor against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1978; 13: 210–3.

Hodges GR Laboratory and clinical evaluations of cefaclor. In: Siegenthaler W Luthy R eds. Current chemotherapy, II. Washington DC: American Society for Microbiology, 1978: 887–8.

Santoro J Levison ME. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic. Antimicrob Agents Chemother 1977; 12: 442–3.

Sinai R In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine. Antimicrob Agents Chemother 1978; 13: 861–4.

Strausbaugh LJ Comparative in vitro activity of five cephalosporin antibiotics against salmonellae. Antimicrob Agents Chemother 1978; 13: 134–5.

Bill NJ Washington JA. Comparison of in vitro activity of cephalexin, cephradine and cefaclor. Antimicrob Agents Chemother 1977; 11: 470.

Chow AW Bednorz D. Comparative in vitro activity of newer cephalosporins against anaerobic bacteria. Antimicrob Agents Chemother 1978; 14: 668–71.

Farrar WE Jr O'Dell NM. Comparative β-lactamase resistance and antistaphylococcal activities of parenterally and orally administered cephalosporins. J Infect Dis 1978; 137: 490–3.

Fekety R Fekety S. Cefaclor, comparative in vitro activity of cefaclor. In: Siegenthaler W Luthy R eds. Current chemotherapy, II. Washington DC: American Society for Microbiology, 1978: 880–1.

Laverdiere M Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins. Antimicrob Agents Chemother 1978; 13: 669–75.

Sanders CC. In vitro studies with cefaclor, a new cephalosporin. Antimicrob Agents Chemother 1977; 12: 490–7.

Scheld WM In vitro susceptibility studies with cefaclor and cephalexin. Antimicrob Agents Chemother 1977; 12: 290–2.

Shadomy S Carver M. Diffusion disk susceptibility testing with cefaclor. Antimicrob Agents Chemother 1978; 13: 228–83.

Shadomy S In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria. Antimicrob Agents Chemother 1977; 12: 609–13.

Shadomy S In vitro activity of five oral cephalosporins against anaerobic pathogenic bacteria. J Infect Dis 1977; 136: 697–700.

Silver MS Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine. Antimicrob Agents Chemother 1977; 12: 591–6.

Watanakunakorn C Glotzbecker C. Comparative susceptibility of Haemophilus species to cefaclor, cefamandole, and five other cephalosporins, and ampicillin, chloramphenicol, and tetracycline. Antimicrob Agents Chemother 1979; 15: 836–8.

Neu HC Fu KP. Cefaclor: in vitro spectrum of activity and beta-lactamase stability. Antimicrob Agents Chemother 1978; 13: 584–8.

Piot P Antibiotic susceptibility of Neisseria gonorrhoeae strains from Europe and Africa. Antimicrob Agents Chemother 1979; 15: 535–9.

Lindan R. Comparison of cefaclor and amoxicillin in the treatment of urinary infections in a chronic disease hospital. Postgrad Med 1979; 55 (Suppl 4): 67.

McLinn SE. Comparative study of cefaclor, a new cephalosporin, and amoxicillin in the treatment of acute otitis media in children. In: Siegenthaler W Luthy R eds. Current chemotherapy, I. Washington DC: American Society for Microbiology, 1978: 123–5.

Stillerman M. Cefaclor and potassium phenoxymethyl penicillin in group A streptococcal pharyngitis. In: Siegenthaler W Luthy R eds. Current chemotherapy, I. Washington DC: American Society for Microbiology, 1977: 127–9.

Finnerty EF Folan DW Jr. Changing antibiotic sensitivities of bacterial skin diseases, office practice, 1977–1978. Cutis 1979; 23: 227–30.

Nelson JD Cefaclor therapy of otitis media in infancy. In: Siegenthaler W Luthy R eds. Current chemotherapy, I. Washington DC: American Society for Microbiology, 1977: 121–3.

Disney FA The use of cefaclor in the treatment of beta-hemolytic streptococcal throat infections in children. Postgrad Med 1979; 55 (Suppl 4): 56.

Wernstedt L Cefaclor therapy in acute exacerbations of chronic bronchitis. Postgrad Med 1979; 55 (Suppl 4): 56.

Mattson KV Cefaclor in the treatment of lower respiratory tract infections. In: Siegenthaler W Luthy R eds. Current chemotherapy, II. Washington DC: American Society for Microbiology, 1978: 888–90.

Mattson KV Treatment of acute bronchitis and pneumonia with cefaclor. Postgrad Med 1979; 55 (Suppl 4): 59.

Mogabgab WJ Treatment of acute bacterial bronchitis and pneumonia with cefaclor. Postgrad Med 1979; 55 (Suppl 4): 62.

Nelson JD Treatment of acute otitis media of infancy with cefaclor. Am J Dis Child 1978; 132: 992–6.

Baraff LJ Oral cefaclor in pediatric respiratory infections. Curr Ther Res 1977; 22: 536–41.

Dillon HC Jr Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections. Postgrad Med 1979; 55 (Suppl): 77.

Gray BM Susceptibility of Staphylococcus aureus to cefaclor and cephalothin: laboratory and clinical studies. Antimicrob Agents Chemother 1978; 13: 988–91.

Nelson JD. Pocketbook of pediatric antimicrobial therapy. 3rd ed. Privately printed, 1979: 77.